Organ Donor Transmission of Rickettsia typhi to Kidney Transplant Recipients, Texas, USA, 2024 [0.03%]
美国得克萨斯州2024年器官捐献者传染巴通体引起肾脏移植受者感染病例
Marcus R Pereira
Marcus R Pereira
The Rapidly Shifting Calibration between KDRI, KDPI, and Graft Survival: Is it Time to Stop Moving the Goalposts? [0.03%]
KDPI与KDRI快速变化的校准及移植物存活率的关系：停止修改标准目标是时候了吗？
Teresa Po-Yu Chiang,Shreeja Patel,Keighly Bradbrook et al.
Teresa Po-Yu Chiang et al.
We sought to understand the potential impacts of a rapidly evolving donor pool on the annual recalibration of the kidney donor profile index (KDPI). Using OPTN data, we examined the kidney donor risk index (KDRI) among deceased kidney donor...
Predictive Value of TTV Viral Load for BKPyV DNAemia Depends on BKPyV-Specific Humoral Immunity in KTRs [0.03%]
TTV病毒载量预测BKPyV DNA血症依赖于KTR中针对BKPyV的体液免疫反应
Ilies Benotmane,Morgane Solis,Anna Duval et al.
Ilies Benotmane et al.
Neutralizing antibodies (NAbs) have been proposed as biomarkers for stratifying BKPyV replication risk, while TTV viral load is recognized as a global immunomarker in kidney transplantation. This study investigates their combined utility to...
Determinants of Virological Outcomes in Kidney Transplant Recipients Treated with Maribavir for Refractory CMV Infection [0.03%]
玛昔培韦治疗难治性巨细胞病毒感染肾移植受者的疗效影响因素分析
N Kasriel,S Alain,I Benotmane et al.
N Kasriel et al.
Maribavir has demonstrated promising efficacy in treating refractory cytomegalovirus (CMV) infections among solid organ transplant recipients; however, factors influencing favourable outcomes remain uncertain. We conducted a retrospective c...
Could a simple flick of the switch increase deceased donor kidney utilization? [0.03%]
一键操作能否增加供体肾脏的利用？
John S Gill,Eoghan White,Vikas Sridhar et al.
John S Gill et al.
Proinflammatory and cytotoxic CD38+HLA-DR+ effector memory CD8+ T cells are peripherally expanded in human cardiac allograft vasculopathy [0.03%]
人心脏移植物血管病中外周活化效应记忆CD8+T细胞的扩增
Yuko Tada,Sujit Silas Armstrong Suthahar,Payel Roy et al.
Yuko Tada et al.
Interferon-γ (IFNG) is thought to play a central role in the pathogenesis of cardiac allograft vasculopathy (CAV) in heart transplant (HTx) patients. However, peripheral lymphocytes participating in the IFNG-axis remain largely unknown in ...
Arnaud Lyon,Alban Longchamp,Korkut Uygun
Arnaud Lyon
Recurrent Primary Biliary Cholangitis After Liver Transplantation: A Global Meta-Analysis of Epidemiology and Risk Factors [0.03%]
肝移植后复发性原发性胆汁性胆管炎的全球流行病学和危险因素 meta 分析
Pedro Robson Costa Passos,Valbert Oliveira Costa Filho,Mariana Macambira Noronha et al.
Pedro Robson Costa Passos et al.
Background: Recurrent primary biliary cholangitis (rPBC) following liver transplantation (LT) is thought to influence graft survival and long-term outcomes, yet its global burden and determinants remain poorly defined. We...
Establishing Best Practices for Obesity and Metabolic Syndrome in Liver Transplantation: Insights from a Modified Delphi-Based Controversies Conference [0.03%]
基于德尔菲法的争议会议在肝移植肥胖和代谢综合征方面建立最佳实践的见解
Jessica P E Davis,Zachary Henry,Pratima Sharma et al.
Jessica P E Davis et al.
Metabolic syndrome and obesity are prevalent and impact liver transplantation (LT) outcomes. Furthermore, the understanding of the complex physiology of obesity and availability of effective anti-obesity interventions has developed rapidly....
A Novel IgG- and IgM-Cleaving Endopeptidase, IceMG, for Antibody-Mediated Rejection [0.03%]
一种新型的IgG和IgM裂解内肽酶IceMG在抗体介导的排斥反应中的作用
Alessandro Martinino,Zishen Li,Timothy J Smith et al.
Alessandro Martinino et al.
Antibody-mediated rejection (AMR) remains a significant barrier to successful outcomes in both allo- and xenotransplantation. In this study, we investigate the efficacy of a novel recombinant endopeptidase, IceMG, which simultaneously cleav...